ResMed, Google ’ s Verily ink sleep-apnea-focused joint venture deal

ResMed (NYSE:RMD) and Google (NSDQ:GOOG) life sciences company Verily said today they inked a new joint venture deal aiming to develop software solutions to improve diagnosis, treatment and care for sleep apnea and other breathing related sleep disorders. The new US-based joint venture will use sleep apnea knowledge from San Diego-based ResMed and Verily’s data analytics technologies in its pursuits, the companies said, and will operate as a separate venture from both ResMed and Verily. “The vast majority of people with sleep apnea don’t realize they have it, and therefore don’t seek accessible, effective treatment to mitigate its effects and long-term health risks. The combined industry expertise, scalable infrastructure, and data analytics capabilities of ResMed and Verily can unlock meaningful ways to identify these individuals and support their journey to improved sleep, health and quality of life,” ResMed chief medical officer Dr. Carlos Nunez said in a prepared statement. “Approaching a widespread health problem like sleep apnea through collecting, organizing and activating health data is central to Verily’s mission. By better identifying at-risk individuals as well as generating real-world evidence regarding the value and effectiveness of treatment, this collaboration has the potential to improve outcomes for millions of people living with sleep apnea, and potentially other related conditions,” Verily ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Respiratory ResMed Inc. Verily Source Type: news

Related Links:

Authors: Zhang L, Wu Q, Zhang Q, Lu G, Yuan Y, Wang T PMID: 30021417 [PubMed - as supplied by publisher]
Source: Panminerva Medica - Category: General Medicine Tags: Panminerva Med Source Type: research
This study aims to use methods of scoring collaterals on CT angiography to analyze changes in collateral circulation in untreated patients with moderate and severe OSAS before and after nasal continuous positive airway pressure (CPAP) treatment. PATIENTS AND METHODS: Ninety-eight moderate and severe OSAS patients treated with nasal CPAP and seventy-four controls that weren't treated with CPAP, were involved in this study. Two independent neuroradiologists evaluated intracranial collaterals by using Miteff scale, modified Tan scale. Intracranial collaterals differences were compared between OSAS group (before and after ...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
The objective of the study was to evaluate the relative prevalence of cardiovascular as well as other comorbidities, in patients with the overlap syndrome, as compared to patients that are diagnosed solely with OSA. PATIENTS AND METHODS: We examined thirty-eight (38) patients (27 men, 11 women) with coexisting COPD and OSA - overlap syndrome (Group 1) vs. 38 patients with OSA-only (Group 2), matched for sex, age, and Body Mass Index (BMI). All patients underwent pulmonary function tests (PFTs), oximetry and overnight polysomnography and were asked about other coexisting chronic diseases and medications. RESULTS: Th...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
[Image from unsplash.com]Companies including 3M and Aura Medical are turning to the popular websites Kickstarter and Indiegogo to get their ideas crowdfunded by people who want them to come to life. The idea behind a crowdfunding website is that if you back the project and donate a certain amount of money, you’ll get something in return, oftentimes the product that is being crowdfunded. In the past, devices like the hoseless, maskless, micro-CPAP Airing have raised over a million dollars. So, while crowdfunding has presented challenges for regulated medical devices, it has been a boon for startups to showcase so...
Source: Mass Device - Category: Medical Devices Authors: Tags: Diagnostics Hospital Care Patient Monitoring Pediatrics Pharmaceuticals Respiratory Software / IT 3m Aura Medical crowdfunding MedTech sleep apnea sleepon startups Virtual Reality Source Type: news
(American Thoracic Society) Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea (OSA) patients who stop using continuous positive airway pressure (CPAP), the standard treatment for OSA, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
ConclusionsSuccessful treatment of OSA with MAD can restore LTL and SIRT1 protein levels in PBMC.Clinical relevanceLTL and SIRT1 protein levels in PBMC can be improved following effective treatment of OSA using MAD.
Source: Clinical Oral Investigations - Category: Dentistry Source Type: research
In this study, we examined the impact of OSA on the employment of soldiers on continuous positive airways pressure (CPAP) therapy by measuring several items: work absenteeism using the Work Productivity and Activity Impairment (WPAI) questionnaire, diurnal hypersomnia, and career advancement. METHODS: A questionnaire was sent by regular mail to 940 soldiers with OSA on CPAP therapy who are insured by the French Military Healthcare Fund (Caisse Nationale Militaire de Sécurité Sociale). RESULTS: Questionnaires were returned by 439 soldiers: mean age 47 years; mean body mass index 29.8kg/m2. Absenteeism ...
Source: Revue d Epidemiologie et de Sante Publique - Category: Epidemiology Tags: Rev Epidemiol Sante Publique Source Type: research
The company is about to grow with an influx of new money and potential initial public offering on the horizon.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news
Conclusions: The confounding factors present in the triad of OSAS, COPD, and obesity prevented the perception of increased daytime sleepiness and high risk for OSAS. We observed no worsening of dyspnea perception or quality of life.RESUMO Objetivo: Avaliar se a presen ça de síndrome da apneia obstrutiva do sono (SAOS) modifica a percepção de queixas respiratórias e de qualidade de vida em pacientes com DPOC por meio de questionários específicos, além de verificar se escalas de sonolência diurna e de rastreamento para SAOS podem ser empregadas na tríade SA...
Source: Jornal Brasileiro de Pneumologia - Category: Respiratory Medicine Source Type: research
Condition:   Obstructive Sleep Apnea Intervention:   Other: CSR remote monitoring Sponsors:   Groupe Medical de Pneumologie, Polyclinique Saint-Laurent;   Slb Pharma;   Vitalaire;   Agence Régionale de Santé - Bretagne;   ResMed Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine